D.C. Mun. Regs. tit. 5-A, § 1102
Administration of Designated or Undesignated Epinephrine Auto-injectors
Effective Feb 24, 201764 DCR 2247Authority: Sections 3(b), (15) and (24) of the State Education Office Establishment Act of 2000, effective October 21, 2000 (D.C. Law 13-176; D.C. Official Code §§ 38-2602(b)(15) and (24) (2012 Repl. & 2016 Supp.)) and the Student Access to Treatment Act of 2007, effective February 2, 2008 (D.C. Law 17-107; D.C. Official Code §§ 38-651.01 et seq.) (2012 Repl. & 2016 Supp.)). Source: Final Rulemaking published at 64 DCR 2247 (February 24, 2017).District of Columbia, Office of the Secretary
1102.1 In emergency circumstances, a certified employee or agent of a public school may administer epinephrine via an undesignated epinephrine auto-injector to a public school student or a designated epinephrine auto-injector to the student to whom it is prescribed if:
- (a) The certified employee or agent believes, in good faith, that the student is suffering from or about to suffer from an anaphylactic reaction; and
- (b) The student is on the public school premises, on a school bus, or on a field trip or other sanctioned excursion away from the public school premises.
1102.2 After the administration of epinephrine via a designated or undesignated epinephrine auto-injector to a public school student pursuant to this chapter, the public school shall comply with the following requirements:
- (a) The student shall be immediately transported by emergency medical services to a hospital emergency department for medical evaluation;
- (b) The principal, or designee, of the public school shall, as soon as practicable, notify the student's emergency contact;
- (c) The certified employee or agent of the public school who administered the epinephrine auto-injector shall document the details of the incident; and
- (d) The principal of the public school, or the principal's designee, shall, within twenty-four (24) hours after the administration of an undesignated epinephrine auto-injector, notify OSSE and the physician, physician assistant, or advanced practice nurse who provided the standing order permitting the use of the undesignated epinephrine auto-injector of its use.
SOURCE: Final Rulemaking published at 64 DCR 2247 (February 24, 2017).